TCG IV Gp, LLC is Director & 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 1 open-market trade across 1 company since 2022, most recently 2024-04-05.
CIK 0001796359
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NGM | 1,000 | $2K |
Shares reported on the most recent Form 4, priced at the 2024-04-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NGM | BUY | 2022-05-17 | 2022-05-19 | $13.33 | $2.0M | -5.6% | +0.1% | +20.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.